Using immunohistochemistry, Bodey and colleagues reported elevated ErbB4 expression in pediatric HGG samples compared with normal brain controls, with ‘strong immunoreactivity’ in GBM samples (97). This evidence concerns the gene ERBB4 and glioblastoma.